School of Medicine
Showing 1-10 of 12,681 Results
-
Oliver O. Aalami, MD
Clinical Professor, Surgery - Vascular Surgery
Current Research and Scholarly InterestsWe launched a national precision medicine PAD trial called, VascTrac (http://vasctrac.stanford.edu/). This trial is mobile phone based and leverages Apple's ResearchKit Platform to monitor a patient's activity both pre- and post-intervention. We are validating mobile phone surveillance for PAD patients and are currently enrolling.
-
Deborah Aarhus
Administrative Director, Vera Moulton Wall Center for Pulmonary Vascular Disease, CVI/Vera Moulton Wall Center
Current Role at StanfordAdministrative Director, Vera Moulton Wall Center for Pulmonary Vascular Disease at Stanford
-
Sumaira Z. Aasi, MD
Clinical Professor, Dermatology
Current Research and Scholarly InterestsHigh risk squamous cell carcinoma; frozen histopathology; reconstructive surgery.
-
Fahim Abbasi
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Fahim Abbasi specializes in diagnosis and treatment of prediabetes and insulin resistance. Dr. Abbasi has a special interest in prevention of diabetes and cardiovascular disease through lifestyle modifications.
-
Carla Abdelnour
Postdoctoral Scholar, Neurology and Neurological Sciences
BioOriginally from Caracas, Venezuela, Dr. Carla Abdelnour received her medical degree at the Central University of Venezuela, and then completed her neurology residency training at the University Hospital Príncipe de Asturias in Madrid, Spain. She conducted her doctorate in Medicine at the Autonomous University of Barcelona working with Drs. Dag Aarsland, Javier Pagonabarraga and Jaime Kulisevsky. Her thesis focused on the influence of Alzheimer´s disease copathology in atrophy patterns, longitudinal cognitive decline, and heterogeneity of patients with dementia with Lewy bodies.
Carla´s main interest is the study of neurodegenerative diseases, especially Lewy body disease. As a Sue Berghoff LBD Research Fellow, her plan is to investigate the impact of different comorbidities in the clinical presentation, cognitive profile, and disease progression of Lewy body disease. Additionally, she wants to study the biological underpinnings of prodromal Lewy body disease to identify potential biomarkers for diagnosis and prognosis.
